Literature DB >> 9721962

Predisposing conditions and pathogens in bacteremia in hospitalized children.

R Berner1, R F Schumacher, S Bartelt, J Forster, M Brandis.   

Abstract

Between 1985 and 1995, 1037 bacteremic episodes were recorded in a pediatric tertiary care center and analyzed retrospectively. Gram-positive bacteria accounted for 719 episodes (68%), gram-negative bacteria for 303 (29%), fungi for 16 (2%), and anaerobes for 12 (1%). In 526 (51%) patients, primarily neonates and oncology patients, a predisposing condition was present. In 390 (38%) episodes a clinical source of infection was documented. Mortality was highest in Pseudomonas bacteremia (45%). Since the bacterial spectrum differed widely between patient groups, the choice of empirical antimicrobial therapy should be based on any underlying condition present in the patient and the clinical source of infection. As anaerobes were rarely isolated. the routine use of anaerobic blood cultures in patients without predisposing conditions does not seem warranted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721962     DOI: 10.1007/bf01709456

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience.

Authors:  I M Gladstone; R A Ehrenkranz; S C Edberg; R S Baltimore
Journal:  Pediatr Infect Dis J       Date:  1990-11       Impact factor: 2.129

2.  Bacteremia due to Escherichia coli: a study of 861 episodes.

Authors:  W R Gransden; S J Eykyn; I Phillips; B Rowe
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

3.  A three-year study of positive blood cultures, with emphasis on prognosis.

Authors:  F J Roberts; I W Geere; A Coldman
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

4.  Increasing Enterobacter bacteremia in pediatric patients.

Authors:  J Andresen; B I Asmar; A S Dajani
Journal:  Pediatr Infect Dis J       Date:  1994-09       Impact factor: 2.129

5.  Assessing the need for anaerobic medium for the recovery of clinically significant blood culture isolates in children.

Authors:  W M Dunne; J Tillman; P L Havens
Journal:  Pediatr Infect Dis J       Date:  1994-03       Impact factor: 2.129

6.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

7.  Polymicrobial bacteremia in children. An 11-year experience.

Authors:  W A Bonadio
Journal:  Am J Dis Child       Date:  1988-11

8.  Septicemia in a university pediatric hospital: a five-year analysis of the bacterial and fungal isolates and outcome of the infections.

Authors:  H Peltola; T Salomaa; A Sivonen; O V Renkonen
Journal:  Scand J Infect Dis       Date:  1987

9.  Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

Authors:  P Y Bochud; P Eggiman; T Calandra; G Van Melle; L Saghafi; P Francioli
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

10.  Neonatal septicaemia.

Authors:  T Vesikari; M Janas; P Grönroos; N Tuppurainen; M Renlund; P Kero; M Koivisto; M Kunnas; K Heinonen; R Nyman
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

View more
  6 in total

1.  A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany.

Authors:  Ulrich von Both; Michael Ruess; Urban Mueller; Kirsten Fluegge; Anna Sander; Reinhard Berner
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Heterogeneity of genotype-phenotype correlation among macrolide-resistant Streptococcus agalactiae isolates.

Authors:  Ulrich von Both; Anna Buerckstuemmer; Kirsten Fluegge; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Group B Streptococci Induce Proinflammatory Responses via a Protein Kinase D1-Dependent Pathway.

Authors:  Kirtikumar Upadhyay; Jeoung-Eun Park; Tae Won Yoon; Priyanka Halder; Young-In Kim; Victoria Metcalfe; Ajay J Talati; B Keith English; Ae-Kyung Yi
Journal:  J Immunol       Date:  2017-05-01       Impact factor: 5.422

4.  Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis.

Authors:  Reinhard Berner; Birgitt Fürll; Felix Stelter; Jana Dröse; Hans-Peter Müller; Christine Schütt
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Secular trends in pediatric bloodstream infections over a 20-year period at a tertiary care hospital in Germany.

Authors:  Markus Hufnagel; Anita Burger; Susanne Bartelt; Philipp Henneke; Reinhard Berner
Journal:  Eur J Pediatr       Date:  2008-01-30       Impact factor: 3.183

6.  Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy.

Authors:  Maria Haller; Matthias Brandis; Reinhard Berner
Journal:  Pediatr Nephrol       Date:  2004-06-18       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.